More than 80% of mutations in KRAS occur at codon 12, found prevalently as G12D substitution in 70% of pancreatic ductal adenocarcinoma (PDAC) (7) and in almost 50% of colorectal carcinoma (CRC) cases (8). Here, KRAS is linked to colorectal carcinoma.